CSIMarket
 
Diplomat Pharmacy Inc   (NYSE: DPLO)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 76
 Employees 2,915
 Revenues (TTM) (Millions $) 5,206
 Net Income (TTM) (Millions $) -649
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 23

Business Description


Diplomat Pharmacy Inc. is a leading provider of specialty pharmacy and infusion services in the United States. The company was founded in 1975 and is headquartered in Flint, Michigan. Diplomat Pharmacy is a publicly traded company on the New York Stock Exchange (NYSE) under the ticker symbol DPLO.

Diplomat Pharmacy specializes in providing medication therapy management and clinical services to patients with complex and chronic conditions such as cancer, HIV/AIDS, hepatitis, multiple sclerosis, rheumatoid arthritis, and other autoimmune disorders. The company also provides specialty infusion services for patients who require medication through an intravenous route.

The company has a nationwide network of specialty pharmacies and infusion centers that allows it to provide personalized and convenient care to patients across the United States. Diplomat Pharmacy's team of experienced pharmacists and clinical staff work closely with patients, healthcare providers, and payers to ensure that patients receive the most effective and cost-efficient treatments available.

Diplomat Pharmacy places a strong emphasis on patient care, clinical excellence, and innovation. The company invests heavily in research and development to stay at the forefront of the latest medical treatments and technology. Diplomat Pharmacy also partners with healthcare providers and payers to develop customized solutions that improve patient outcomes and reduce healthcare costs.

Diplomat Pharmacy has received numerous awards and recognitions for its innovative and patient-centered approach to healthcare. The company has also been recognized for its commitment to diversity and inclusion, environmental sustainability, and corporate social responsibility.

In 2019, Diplomat Pharmacy was acquired by UnitedHealth Group, a leading diversified healthcare company. Under the ownership of UnitedHealth Group, Diplomat Pharmacy continues to provide high-quality specialty pharmacy and infusion services to patients across the United States.


   Company Address: 4100 S. Saginaw Street Flint 48507 MI
   Company Phone Number: 720-4450   Stock Exchange / Ticker: NYSE DPLO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.01
Working Capital Ratio 0.55
Leverage Ratio (MRQ) 7.87
Total Debt to Equity 4.18
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -8.68 $
Revenues (TTM) 68.95 $
Cash Flow (TTM) 0.02 $
Cash 0.11 $
Book Value 1.74 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,786,023
Net Income per Employee (TTM) -222,665
Receivable Turnover Ratio (TTM) 15.72
Inventory Turnover Ratio (TTM) 26.38
Asset Turnover Ratio (TTM) 3.86

Profitability Ratios Current
Gross Margin (MRQ) 4.87 %
Operating Margin (MRQ) -12.9 %
Net Margin (MRQ) -13.62 %
Net Cash Flow Margin (MRQ) 0.29 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.